Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Humira Pen
Active Ingredient: Adalimumab 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturers: Abbott Laboratories Limited, Queenborough, Kent, United Kingdom
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Product: Otrivin Adult Nasal Drops
Active Ingredient: Xylometazoline hydrochloride 0.1%w/v
Dosage Form: Nasal drops
New Zealand Sponsor: Novartis Consumer Health Australasia Pty. Limited
Manufacturer: Novartis Consumer Health SA, Prangins, Nyon, Switzerland
Product: Otrivin Adult Nasal Spray
Active Ingredient: Xylometazoline hydrochloride 0.1%w/v
Dosage Form: Nasal spray solution
New Zealand Sponsor: Novartis Consumer Health Australasia Pty. Limited
Manufacturer: Novartis Consumer Health SA, Prangins, Nyon, Switzerland
Product: Otrivin Junior Nasal drops
Active Ingredient: Xylometazoline hydrochloride 0.05%w/v
Dosage Form: Nasal drops
New Zealand Sponsor: Novartis Consumer Health Australasia Pty. Limited
Manufacturer: Novartis Consumer Health SA, Prangins, Nyon, Switzerland
Product: Otrivin Junior Nasal Spray
Active Ingredient: Xylometazoline hydrochloride 0.05%w/v
Dosage Form: Nasal spray solution
New Zealand Sponsor: Novartis Consumer Health Australasia Pty. Limited
Manufacturer: Novartis Consumer Health SA, Prangins, Nyon, Switzerland
Product: Ventavis
Active Ingredient: Iloprost 20µg
Dosage Form: Solution for inhalation
New Zealand Sponsor: Schering (NZ) Limited
Manufacturer: Berlimed SA, Pologono Industrial Santa Rosa, Henares, Madrid, Spain
Dated this 12th day of April 2007.
MARK JACOBS, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on
6 July 2001).